RENASANT CORP (RNST)

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close

39.01 on 9 Oct 2026

1 buy9 sales at will0 planned sales

Fiscal year 2025, ended 31 Dec 2025, as filed

Net income

$181.27M

Free cash flow

$237.75M

Return on equity

4.7%

Debt to equity

0.13

EPS growth, 1 yr

-36.7%

Fiscal years, as filed with the SEC · point at a year for the detail

RevenueNet incomeLoss

From Form 4, most recent first

Date	Insider	Type	Value	Of own stake
3 Aug 2026	MCGRAW EDWARD ROBINSON Director	Sold at will	$1.54M	14.2%
29 May 2026	Engel Connie L Director	Sold at will	$51.41K	7.5%
19 May 2026	DALE ALBERT J III Director	Sold at will	$65.66K	4.0%
14 May 2026	WAYCASTER C MITCHELL Executive Vice Chairman	Sold at will	$501.81K	6.5%
4 Mar 2026	Hutcheson Kelly EVP/Chief Accounting Officer	Sold at will	$52.18K	7.5%
13 Feb 2026	COLE M RAY JR SEVP and Executive Advisor	Sold at will	$769.45K	15.9%

48out of 100

Profitability 60

Financial strength 56

Growth 25

Insiders 50

Strongest on profitability (60), weakest on growth (25). A score of the business, not of the price.

Last 12 months

Only here

Bought

$69.58K

1 buy, 1 buyer

Sold

$3.72M

9 sales

Planned sales

under a 10b5-1 plan